Enhancing the efficacy of precision oncology-based therapy in rhabdomyosarcoma

Ended Project Grant Awarded Last action

Award ID
W81XWH2110795
Recipient
Awarding agency
Obligated
$1,528,652

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Place of performance
Seattle, WA 98195, USA

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

The Department of the Army Medical Command awarded a $1,528,652 Project Grant to the University of Washington under the Military Medical Research and Development program (CFDA 12.420) to enhance the efficacy of precision oncology-based therapy in rhabdomyosarcoma. The three-year award beginning in August 2021 will support the University of Washington's research into investigating medical solutions for rhabdomyosarcoma on the battlefield and transforming health care for service members and the public through innovative and impactful medical research. A sub-award of $TBD was provided to Washington State University to support enhancing the efficacy of precision oncology-based therapy in rhabdomyosarcoma in collaboration with the University of Washington.

Quick answers

Who received award W81XWH2110795?

W81XWH2110795 was awarded to University Of Washington by Medical Command (Department of the Army) on August 15, 2021.

How much is award W81XWH2110795 worth?

$1,528,652 has been obligated on W81XWH2110795.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login